DEF 14A: TETE Seeks Shareholder Approval for Extension to Complete Business Combination

Sentiment:

Proxy Statement


Technology & Telecommunication Acquisition Corporation (TETE) is seeking shareholder approval to extend the deadline for completing a business combination from May 20, 2024, to January 20, 2025.

Delay expectedThe company is seeking an extension of the deadline to complete its business combination, indicating a delay in the initial timeline.

Summary

  • Technology & Telecommunication Acquisition Corporation (TETE) is seeking shareholder approval for an extension to complete its proposed business combination with Bradbury Capital Holdings Inc.
  • The company is requesting the ability to extend the deadline up to seven times, each for an additional month, from May 20, 2024, to January 20, 2025.
  • Shareholders will vote on proposals to amend the company's Articles of Association and Trust Agreement to allow for the extension.
  • The Sponsor would deposit the lesser of $60,000 or $0.02 per outstanding share into the trust account for each one-month extension.
  • If the extension is not approved, TETE will liquidate and return funds to public shareholders.
  • Shareholders have the right to redeem their shares in connection with the extension.
  • The estimated redemption price per share is approximately $11.89 as of May 23, 2024.
  • The board of directors unanimously recommends voting in favor of the extension proposals.
  • An extraordinary general meeting is scheduled for June 7, 2024, to vote on the proposals.

Sentiment

Score: 6

Explanation: The document is neutral in tone, presenting the facts of the proposed extension and the associated shareholder vote. While the board recommends approval, the document also outlines the consequences of not approving the extension, providing a balanced view.

Positives

  • The board believes the extension is in the best interest of shareholders, providing additional time to complete the proposed business combination.
  • The extension allows TETE to continue its efforts to consummate a business combination, potentially providing significant benefits to shareholders.
  • Shareholders have the right to redeem their shares if they do not wish to sustain their investment for the extended period.
  • The Sponsor is willing to deposit additional funds into the trust account to facilitate the extension.

Negatives

  • If the extension is not approved, TETE will be forced to liquidate, precluding the completion of a business combination.
  • Significant redemptions at the extraordinary general meeting are expected.
  • Exercising redemption rights might result in receiving slightly less per share than selling in the open market, depending on the market price.
  • There is no assurance that shareholders will be able to sell their shares in the open market.

Risks

  • There is a risk that TETE will not be able to complete a business combination even with the extension.
  • Significant redemptions could reduce the amount remaining in the trust account.
  • The Sponsor may not elect to extend the Termination Date by further funding the Trust Account.
  • The proposed business combination may be subject to U.S. foreign investment regulations and review by a U.S. government entity such as the Committee on Foreign Investment in the United States (CFIUS), or ultimately prohibited.

Future Outlook

TETE intends to continue seeking a business combination until the Extended Date if the extension proposals are approved. The company plans to hold an additional extraordinary general meeting to approve a business combination at a future date.

Management Comments

  • The board of directors believes that it is in the best interests of TETE and its shareholders to extend the termination date.
  • The board believes a Business Combination will provide significant benefits to its shareholders.

Industry Context

SPACs often seek extensions to complete business combinations due to market conditions or difficulties in finding suitable targets. This announcement reflects the challenges faced by SPACs in the current environment.

Comparison to Industry Standards

  • SPACs like TETE often face challenges in completing mergers within the initial timeframe, leading to requests for extensions.
  • The redemption price of $11.89 is comparable to other SPACs nearing their termination dates, reflecting the trust account value.
  • The Sponsor's willingness to deposit additional funds for extensions is a common practice, similar to other SPACs seeking more time.
  • Comparable companies include other SPACs that have sought extensions, such as Gores Metropoulos II, Inc. which extended its deadline to complete a business combination with Sonder Holdings Inc.

Related Party Transactions

  • The Sponsor has agreed to loan the Company up to a total of $2,300,000 in connection with its funding of the two automatic extensions permitted the TETEs Articles of Association.
  • Each extension payment is loaned to the Company by the Sponsor pursuant to a promissory note and the Company will repay the aggregate amount contributed by the Sponsor for the extensions at Closing.
  • The loans are not interest-bearing and may be converted into ordinary shares at Closing at the option of the Sponsor.

Stakeholder Impact

  • Shareholders can choose to redeem their shares or remain invested for the extended period.
  • If the extension is not approved, shareholders will receive a pro rata share of the trust account upon liquidation.
  • The Sponsor and management have incentives tied to completing a business combination.
  • Employees and other stakeholders are impacted by the uncertainty surrounding the company's future.

Next Steps

  • Shareholders to vote on the extension proposals at the Extraordinary General Meeting on June 7, 2024.
  • If approved, TETE will file amended Articles of Association and continue seeking a business combination.
  • TETE intends to call an additional extraordinary general meeting of its shareholders to approve a Business Combination at a future date.

Key Dates

DateDescription
October 21, 2021TETE incorporated as a Cayman Islands exempted company.
February 8, 2022Date of the Investment Management Trust Agreement between TETE and Continental Stock Transfer & Trust Company.
February 10, 2022TETEs final prospectus filed with the SEC in connection with TETEs initial public offering.
February 11, 2022TETE consummated its initial public offering (IPO).
January 18, 2023TETE held an extraordinary meeting of shareholders to approve proposals to extend the Combination Period.
February 21, 2023TETE issued an unsecured promissory note to its Sponsor, in the amount of $656,747 which amount was deposited into the trust account to extend the available time to complete a business combination to February 20, 2023.
August 2, 2023Date of the amended and restated agreement and plan of merger between TETE and Bradbury Capital Holdings Inc.
July 18, 2023TETE held an extraordinary meeting of shareholders to approve proposals to extend the Combination Period.
May 7, 2024Record Date for determining TETE shareholders entitled to receive notice of and vote at the Extraordinary General Meeting.
May 20, 2024Original Termination Date for TETE to complete a business combination.
May 23, 2024Date for calculating the approximate redemption price per Public Share ($11.89).
May 28, 2024Date of the proxy statement and first mailing to shareholders.
June 7, 2024Date of the Extraordinary General Meeting to vote on the extension proposals.
January 20, 2025Extended Date for TETE to complete a business combination if the extension proposals are approved.

Keywords

business combination, extension, redemption, shareholders, TETE, trust account, amendment, liquidation, sponsor, shares

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.